Global Radiopharmaceutical Supply, Demand and Key Producers, 2026-2032
The global Radiopharmaceutical market size is expected to reach $ 20850 million by 2032, rising at a market growth of 9.0% CAGR during the forecast period (2026-2032).
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.In 2024, global Radiopharmaceuticals production reached approximately 139.47 m units, with an average global market price of around US$ 68.49 perunit.The average gross profit margin of this product is 72%.
The radiopharmaceutical market is driven primarily by the growing prevalence of cancer and cardiovascular diseases, which require precise diagnostic tools for early detection and treatment. The increasing adoption of nuclear medicine imaging techniques, such as PET and SPECT scans, has further fueled demand for radiopharmaceuticals. Additionally, technological advancements in radiopharmaceuticals, along with the development of new radioisotopes for more targeted therapies, are expanding the applications of these drugs, making them critical in personalized medicine.
Despite the promising growth, the radiopharmaceutical market faces significant challenges, including the high cost of production and the short half-life of many radioisotopes, which complicates distribution and storage. Regulatory hurdles are another barrier, as radiopharmaceuticals require stringent approval processes due to their radioactive nature. Moreover, limited availability of specialized infrastructure and the shortage of trained professionals in nuclear medicine also hinder widespread adoption, especially in developing regions.
There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions. In developed countries (a quarter of the world population) about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this.
Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs, or to treat disease. In most cases, the information is used by physicians to make a quick diagnosis of the patient's illness. The thyroid, bones, heart, liver, and many other organs can be easily imaged, and disorders in their function revealed. In some cases radiation can be used to treat diseased organs, or tumours.
Over 10,000 hospitals worldwide use radioisotopes in medicine, and about 90% of the procedures are for diagnosis. The most common radioisotope used in diagnosis is technetium-99 (Tc-99m) accounting for about 80% of all nuclear medicine procedures and 85% of diagnostic scans in nuclear medicine worldwide.Over 50 million nuclear medicine procedures are performed each year, and demand for radioisotopes is increasing.
This report studies the global Radiopharmaceutical production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Radiopharmaceutical and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Radiopharmaceutical that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Radiopharmaceutical total production and demand, 2021-2032, (K Dose)
Global Radiopharmaceutical total production value, 2021-2032, (USD Million)
Global Radiopharmaceutical production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Radiopharmaceutical consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Radiopharmaceutical domestic production, consumption, key domestic manufacturers and share
Global Radiopharmaceutical production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Radiopharmaceutical production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Radiopharmaceutical production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Radiopharmaceutical market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cardinal Health, GE Healthcare, Lantheus Medical Imaging, Bayer, Eli Lilly, Bracco Imaging, Curium Pharma, Jubilant Pharmova, Aurobindo Pharma, Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Radiopharmaceutical market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (USD/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Radiopharmaceutical Market, By Region:
1. How big is the global Radiopharmaceutical market?
2. What is the demand of the global Radiopharmaceutical market?
3. What is the year over year growth of the global Radiopharmaceutical market?
4. What is the production and production value of the global Radiopharmaceutical market?
5. Who are the key producers in the global Radiopharmaceutical market?
6. What are the growth factors driving the market demand?
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.In 2024, global Radiopharmaceuticals production reached approximately 139.47 m units, with an average global market price of around US$ 68.49 perunit.The average gross profit margin of this product is 72%.
The radiopharmaceutical market is driven primarily by the growing prevalence of cancer and cardiovascular diseases, which require precise diagnostic tools for early detection and treatment. The increasing adoption of nuclear medicine imaging techniques, such as PET and SPECT scans, has further fueled demand for radiopharmaceuticals. Additionally, technological advancements in radiopharmaceuticals, along with the development of new radioisotopes for more targeted therapies, are expanding the applications of these drugs, making them critical in personalized medicine.
Despite the promising growth, the radiopharmaceutical market faces significant challenges, including the high cost of production and the short half-life of many radioisotopes, which complicates distribution and storage. Regulatory hurdles are another barrier, as radiopharmaceuticals require stringent approval processes due to their radioactive nature. Moreover, limited availability of specialized infrastructure and the shortage of trained professionals in nuclear medicine also hinder widespread adoption, especially in developing regions.
There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions. In developed countries (a quarter of the world population) about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this.
Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs, or to treat disease. In most cases, the information is used by physicians to make a quick diagnosis of the patient's illness. The thyroid, bones, heart, liver, and many other organs can be easily imaged, and disorders in their function revealed. In some cases radiation can be used to treat diseased organs, or tumours.
Over 10,000 hospitals worldwide use radioisotopes in medicine, and about 90% of the procedures are for diagnosis. The most common radioisotope used in diagnosis is technetium-99 (Tc-99m) accounting for about 80% of all nuclear medicine procedures and 85% of diagnostic scans in nuclear medicine worldwide.Over 50 million nuclear medicine procedures are performed each year, and demand for radioisotopes is increasing.
This report studies the global Radiopharmaceutical production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Radiopharmaceutical and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Radiopharmaceutical that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Radiopharmaceutical total production and demand, 2021-2032, (K Dose)
Global Radiopharmaceutical total production value, 2021-2032, (USD Million)
Global Radiopharmaceutical production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Radiopharmaceutical consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Radiopharmaceutical domestic production, consumption, key domestic manufacturers and share
Global Radiopharmaceutical production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Radiopharmaceutical production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Radiopharmaceutical production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Radiopharmaceutical market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cardinal Health, GE Healthcare, Lantheus Medical Imaging, Bayer, Eli Lilly, Bracco Imaging, Curium Pharma, Jubilant Pharmova, Aurobindo Pharma, Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Radiopharmaceutical market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (USD/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Radiopharmaceutical Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Diagnostic Radiopharmaceuticals
- Therapeutic Radiopharmaceuticals
- Technetium-99m
- Fluorine-18
- Iodine-123
- Iodine-131
- Radium-223
- Iodine-125
- Other
- Oncology
- Cardiology
- Other
- Hospital
- Inmaging Center
- Others
- Cardinal Health
- GE Healthcare
- Lantheus Medical Imaging
- Bayer
- Eli Lilly
- Bracco Imaging
- Curium Pharma
- Jubilant Pharmova
- Aurobindo Pharma
- Novartis
- Siemens
- NTP Radioisotopes
- ANSTO
- Polatom
- China Isotope & Radiation
- Dongcheng
- Seed Medical
1. How big is the global Radiopharmaceutical market?
2. What is the demand of the global Radiopharmaceutical market?
3. What is the year over year growth of the global Radiopharmaceutical market?
4. What is the production and production value of the global Radiopharmaceutical market?
5. Who are the key producers in the global Radiopharmaceutical market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 SCADA Introduction
1.2 World SCADA Market Size & Forecast (2021 & 2025 & 2032)
1.3 World SCADA Total Market by Region (by Headquarter Location)
1.3.1 World SCADA Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company SCADA Revenue (2021-2032)
1.3.3 China Based Company SCADA Revenue (2021-2032)
1.3.4 Europe Based Company SCADA Revenue (2021-2032)
1.3.5 Japan Based Company SCADA Revenue (2021-2032)
1.3.6 South Korea Based Company SCADA Revenue (2021-2032)
1.3.7 ASEAN Based Company SCADA Revenue (2021-2032)
1.3.8 India Based Company SCADA Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 SCADA Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World SCADA Consumption Value (2021-2032)
2.2 World SCADA Consumption Value by Region
2.2.1 World SCADA Consumption Value by Region (2021-2026)
2.2.2 World SCADA Consumption Value Forecast by Region (2027-2032)
2.3 United States SCADA Consumption Value (2021-2032)
2.4 China SCADA Consumption Value (2021-2032)
2.5 Europe SCADA Consumption Value (2021-2032)
2.6 Japan SCADA Consumption Value (2021-2032)
2.7 South Korea SCADA Consumption Value (2021-2032)
2.8 ASEAN SCADA Consumption Value (2021-2032)
2.9 India SCADA Consumption Value (2021-2032)
3 WORLD SCADA COMPANIES COMPETITIVE ANALYSIS
3.1 World SCADA Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global SCADA Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for SCADA in 2025
3.2.3 Global Concentration Ratios (CR8) for SCADA in 2025
3.3 SCADA Company Evaluation Quadrant
3.4 SCADA Market: Overall Company Footprint Analysis
3.4.1 SCADA Market: Region Footprint
3.4.2 SCADA Market: Company Product Type Footprint
3.4.3 SCADA Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: SCADA Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: SCADA Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: SCADA Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: SCADA Consumption Value Comparison
4.2.1 United States VS China: SCADA Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: SCADA Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based SCADA Companies and Market Share, 2021-2026
4.3.1 United States Based SCADA Companies, Headquarters (States, Country)
4.3.2 United States Based Companies SCADA Revenue, (2021-2026)
4.4 China Based Companies SCADA Revenue and Market Share, 2021-2026
4.4.1 China Based SCADA Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies SCADA Revenue, (2021-2026)
4.5 Rest of World Based SCADA Companies and Market Share, 2021-2026
4.5.1 Rest of World Based SCADA Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies SCADA Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World SCADA Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Hardware
5.2.2 Software
5.2.3 Services
5.3 Market Segment by Type
5.3.1 World SCADA Market Size by Type (2021-2026)
5.3.2 World SCADA Market Size by Type (2027-2032)
5.3.3 World SCADA Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World SCADA Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Power & Energy
6.2.2 Oil & Gas Industry
6.2.3 Water & Waste Control
6.2.4 Telecommunications
6.2.5 Transportation
6.2.6 Manufacturing Industry
6.2.7 Others
6.3 Market Segment by Application
6.3.1 World SCADA Market Size by Application (2021-2026)
6.3.2 World SCADA Market Size by Application (2027-2032)
6.3.3 World SCADA Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Schneider Electric SE (France)
7.1.1 Schneider Electric SE (France) Details
7.1.2 Schneider Electric SE (France) Major Business
7.1.3 Schneider Electric SE (France) SCADA Product and Services
7.1.4 Schneider Electric SE (France) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Schneider Electric SE (France) Recent Developments/Updates
7.1.6 Schneider Electric SE (France) Competitive Strengths & Weaknesses
7.2 ABB (Switzerland)
7.2.1 ABB (Switzerland) Details
7.2.2 ABB (Switzerland) Major Business
7.2.3 ABB (Switzerland) SCADA Product and Services
7.2.4 ABB (Switzerland) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 ABB (Switzerland) Recent Developments/Updates
7.2.6 ABB (Switzerland) Competitive Strengths & Weaknesses
7.3 Siemens AG (Germany)
7.3.1 Siemens AG (Germany) Details
7.3.2 Siemens AG (Germany) Major Business
7.3.3 Siemens AG (Germany) SCADA Product and Services
7.3.4 Siemens AG (Germany) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Siemens AG (Germany) Recent Developments/Updates
7.3.6 Siemens AG (Germany) Competitive Strengths & Weaknesses
7.4 Emerson (US)
7.4.1 Emerson (US) Details
7.4.2 Emerson (US) Major Business
7.4.3 Emerson (US) SCADA Product and Services
7.4.4 Emerson (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Emerson (US) Recent Developments/Updates
7.4.6 Emerson (US) Competitive Strengths & Weaknesses
7.5 Rockwell Automation Inc. (US)
7.5.1 Rockwell Automation Inc. (US) Details
7.5.2 Rockwell Automation Inc. (US) Major Business
7.5.3 Rockwell Automation Inc. (US) SCADA Product and Services
7.5.4 Rockwell Automation Inc. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Rockwell Automation Inc. (US) Recent Developments/Updates
7.5.6 Rockwell Automation Inc. (US) Competitive Strengths & Weaknesses
7.6 Honeywell International Inc. (US)
7.6.1 Honeywell International Inc. (US) Details
7.6.2 Honeywell International Inc. (US) Major Business
7.6.3 Honeywell International Inc. (US) SCADA Product and Services
7.6.4 Honeywell International Inc. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Honeywell International Inc. (US) Recent Developments/Updates
7.6.6 Honeywell International Inc. (US) Competitive Strengths & Weaknesses
7.7 Mitsubishi Electric (Japan)
7.7.1 Mitsubishi Electric (Japan) Details
7.7.2 Mitsubishi Electric (Japan) Major Business
7.7.3 Mitsubishi Electric (Japan) SCADA Product and Services
7.7.4 Mitsubishi Electric (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Mitsubishi Electric (Japan) Recent Developments/Updates
7.7.6 Mitsubishi Electric (Japan) Competitive Strengths & Weaknesses
7.8 Omron Corporation (Japan)
7.8.1 Omron Corporation (Japan) Details
7.8.2 Omron Corporation (Japan) Major Business
7.8.3 Omron Corporation (Japan) SCADA Product and Services
7.8.4 Omron Corporation (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Omron Corporation (Japan) Recent Developments/Updates
7.8.6 Omron Corporation (Japan) Competitive Strengths & Weaknesses
7.9 General Electric Co. (US)
7.9.1 General Electric Co. (US) Details
7.9.2 General Electric Co. (US) Major Business
7.9.3 General Electric Co. (US) SCADA Product and Services
7.9.4 General Electric Co. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 General Electric Co. (US) Recent Developments/Updates
7.9.6 General Electric Co. (US) Competitive Strengths & Weaknesses
7.10 Yokogawa Electric Corporation (Japan)
7.10.1 Yokogawa Electric Corporation (Japan) Details
7.10.2 Yokogawa Electric Corporation (Japan) Major Business
7.10.3 Yokogawa Electric Corporation (Japan) SCADA Product and Services
7.10.4 Yokogawa Electric Corporation (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Yokogawa Electric Corporation (Japan) Recent Developments/Updates
7.10.6 Yokogawa Electric Corporation (Japan) Competitive Strengths & Weaknesses
7.11 Larsen & Toubro (India)
7.11.1 Larsen & Toubro (India) Details
7.11.2 Larsen & Toubro (India) Major Business
7.11.3 Larsen & Toubro (India) SCADA Product and Services
7.11.4 Larsen & Toubro (India) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Larsen & Toubro (India) Recent Developments/Updates
7.11.6 Larsen & Toubro (India) Competitive Strengths & Weaknesses
7.12 M.B. Control & Systems Pvt. Ltd (India)
7.12.1 M.B. Control & Systems Pvt. Ltd (India) Details
7.12.2 M.B. Control & Systems Pvt. Ltd (India) Major Business
7.12.3 M.B. Control & Systems Pvt. Ltd (India) SCADA Product and Services
7.12.4 M.B. Control & Systems Pvt. Ltd (India) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 M.B. Control & Systems Pvt. Ltd (India) Recent Developments/Updates
7.12.6 M.B. Control & Systems Pvt. Ltd (India) Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 SCADA Industry Chain
8.2 SCADA Upstream Analysis
8.3 SCADA Midstream Analysis
8.4 SCADA Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 SCADA Introduction
1.2 World SCADA Market Size & Forecast (2021 & 2025 & 2032)
1.3 World SCADA Total Market by Region (by Headquarter Location)
1.3.1 World SCADA Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company SCADA Revenue (2021-2032)
1.3.3 China Based Company SCADA Revenue (2021-2032)
1.3.4 Europe Based Company SCADA Revenue (2021-2032)
1.3.5 Japan Based Company SCADA Revenue (2021-2032)
1.3.6 South Korea Based Company SCADA Revenue (2021-2032)
1.3.7 ASEAN Based Company SCADA Revenue (2021-2032)
1.3.8 India Based Company SCADA Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 SCADA Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World SCADA Consumption Value (2021-2032)
2.2 World SCADA Consumption Value by Region
2.2.1 World SCADA Consumption Value by Region (2021-2026)
2.2.2 World SCADA Consumption Value Forecast by Region (2027-2032)
2.3 United States SCADA Consumption Value (2021-2032)
2.4 China SCADA Consumption Value (2021-2032)
2.5 Europe SCADA Consumption Value (2021-2032)
2.6 Japan SCADA Consumption Value (2021-2032)
2.7 South Korea SCADA Consumption Value (2021-2032)
2.8 ASEAN SCADA Consumption Value (2021-2032)
2.9 India SCADA Consumption Value (2021-2032)
3 WORLD SCADA COMPANIES COMPETITIVE ANALYSIS
3.1 World SCADA Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global SCADA Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for SCADA in 2025
3.2.3 Global Concentration Ratios (CR8) for SCADA in 2025
3.3 SCADA Company Evaluation Quadrant
3.4 SCADA Market: Overall Company Footprint Analysis
3.4.1 SCADA Market: Region Footprint
3.4.2 SCADA Market: Company Product Type Footprint
3.4.3 SCADA Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: SCADA Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: SCADA Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: SCADA Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: SCADA Consumption Value Comparison
4.2.1 United States VS China: SCADA Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: SCADA Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based SCADA Companies and Market Share, 2021-2026
4.3.1 United States Based SCADA Companies, Headquarters (States, Country)
4.3.2 United States Based Companies SCADA Revenue, (2021-2026)
4.4 China Based Companies SCADA Revenue and Market Share, 2021-2026
4.4.1 China Based SCADA Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies SCADA Revenue, (2021-2026)
4.5 Rest of World Based SCADA Companies and Market Share, 2021-2026
4.5.1 Rest of World Based SCADA Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies SCADA Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World SCADA Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Hardware
5.2.2 Software
5.2.3 Services
5.3 Market Segment by Type
5.3.1 World SCADA Market Size by Type (2021-2026)
5.3.2 World SCADA Market Size by Type (2027-2032)
5.3.3 World SCADA Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World SCADA Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Power & Energy
6.2.2 Oil & Gas Industry
6.2.3 Water & Waste Control
6.2.4 Telecommunications
6.2.5 Transportation
6.2.6 Manufacturing Industry
6.2.7 Others
6.3 Market Segment by Application
6.3.1 World SCADA Market Size by Application (2021-2026)
6.3.2 World SCADA Market Size by Application (2027-2032)
6.3.3 World SCADA Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Schneider Electric SE (France)
7.1.1 Schneider Electric SE (France) Details
7.1.2 Schneider Electric SE (France) Major Business
7.1.3 Schneider Electric SE (France) SCADA Product and Services
7.1.4 Schneider Electric SE (France) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Schneider Electric SE (France) Recent Developments/Updates
7.1.6 Schneider Electric SE (France) Competitive Strengths & Weaknesses
7.2 ABB (Switzerland)
7.2.1 ABB (Switzerland) Details
7.2.2 ABB (Switzerland) Major Business
7.2.3 ABB (Switzerland) SCADA Product and Services
7.2.4 ABB (Switzerland) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 ABB (Switzerland) Recent Developments/Updates
7.2.6 ABB (Switzerland) Competitive Strengths & Weaknesses
7.3 Siemens AG (Germany)
7.3.1 Siemens AG (Germany) Details
7.3.2 Siemens AG (Germany) Major Business
7.3.3 Siemens AG (Germany) SCADA Product and Services
7.3.4 Siemens AG (Germany) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Siemens AG (Germany) Recent Developments/Updates
7.3.6 Siemens AG (Germany) Competitive Strengths & Weaknesses
7.4 Emerson (US)
7.4.1 Emerson (US) Details
7.4.2 Emerson (US) Major Business
7.4.3 Emerson (US) SCADA Product and Services
7.4.4 Emerson (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Emerson (US) Recent Developments/Updates
7.4.6 Emerson (US) Competitive Strengths & Weaknesses
7.5 Rockwell Automation Inc. (US)
7.5.1 Rockwell Automation Inc. (US) Details
7.5.2 Rockwell Automation Inc. (US) Major Business
7.5.3 Rockwell Automation Inc. (US) SCADA Product and Services
7.5.4 Rockwell Automation Inc. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Rockwell Automation Inc. (US) Recent Developments/Updates
7.5.6 Rockwell Automation Inc. (US) Competitive Strengths & Weaknesses
7.6 Honeywell International Inc. (US)
7.6.1 Honeywell International Inc. (US) Details
7.6.2 Honeywell International Inc. (US) Major Business
7.6.3 Honeywell International Inc. (US) SCADA Product and Services
7.6.4 Honeywell International Inc. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Honeywell International Inc. (US) Recent Developments/Updates
7.6.6 Honeywell International Inc. (US) Competitive Strengths & Weaknesses
7.7 Mitsubishi Electric (Japan)
7.7.1 Mitsubishi Electric (Japan) Details
7.7.2 Mitsubishi Electric (Japan) Major Business
7.7.3 Mitsubishi Electric (Japan) SCADA Product and Services
7.7.4 Mitsubishi Electric (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Mitsubishi Electric (Japan) Recent Developments/Updates
7.7.6 Mitsubishi Electric (Japan) Competitive Strengths & Weaknesses
7.8 Omron Corporation (Japan)
7.8.1 Omron Corporation (Japan) Details
7.8.2 Omron Corporation (Japan) Major Business
7.8.3 Omron Corporation (Japan) SCADA Product and Services
7.8.4 Omron Corporation (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Omron Corporation (Japan) Recent Developments/Updates
7.8.6 Omron Corporation (Japan) Competitive Strengths & Weaknesses
7.9 General Electric Co. (US)
7.9.1 General Electric Co. (US) Details
7.9.2 General Electric Co. (US) Major Business
7.9.3 General Electric Co. (US) SCADA Product and Services
7.9.4 General Electric Co. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 General Electric Co. (US) Recent Developments/Updates
7.9.6 General Electric Co. (US) Competitive Strengths & Weaknesses
7.10 Yokogawa Electric Corporation (Japan)
7.10.1 Yokogawa Electric Corporation (Japan) Details
7.10.2 Yokogawa Electric Corporation (Japan) Major Business
7.10.3 Yokogawa Electric Corporation (Japan) SCADA Product and Services
7.10.4 Yokogawa Electric Corporation (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Yokogawa Electric Corporation (Japan) Recent Developments/Updates
7.10.6 Yokogawa Electric Corporation (Japan) Competitive Strengths & Weaknesses
7.11 Larsen & Toubro (India)
7.11.1 Larsen & Toubro (India) Details
7.11.2 Larsen & Toubro (India) Major Business
7.11.3 Larsen & Toubro (India) SCADA Product and Services
7.11.4 Larsen & Toubro (India) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Larsen & Toubro (India) Recent Developments/Updates
7.11.6 Larsen & Toubro (India) Competitive Strengths & Weaknesses
7.12 M.B. Control & Systems Pvt. Ltd (India)
7.12.1 M.B. Control & Systems Pvt. Ltd (India) Details
7.12.2 M.B. Control & Systems Pvt. Ltd (India) Major Business
7.12.3 M.B. Control & Systems Pvt. Ltd (India) SCADA Product and Services
7.12.4 M.B. Control & Systems Pvt. Ltd (India) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 M.B. Control & Systems Pvt. Ltd (India) Recent Developments/Updates
7.12.6 M.B. Control & Systems Pvt. Ltd (India) Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 SCADA Industry Chain
8.2 SCADA Upstream Analysis
8.3 SCADA Midstream Analysis
8.4 SCADA Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Radiopharmaceutical Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Radiopharmaceutical Production Value by Region (2021-2026) & (USD Million)
Table 3. World Radiopharmaceutical Production Value by Region (2027-2032) & (USD Million)
Table 4. World Radiopharmaceutical Production Value Market Share by Region (2021-2026)
Table 5. World Radiopharmaceutical Production Value Market Share by Region (2027-2032)
Table 6. World Radiopharmaceutical Production by Region (2021-2026) & (K Dose)
Table 7. World Radiopharmaceutical Production by Region (2027-2032) & (K Dose)
Table 8. World Radiopharmaceutical Production Market Share by Region (2021-2026)
Table 9. World Radiopharmaceutical Production Market Share by Region (2027-2032)
Table 10. World Radiopharmaceutical Average Price by Region (2021-2026) & (USD/Dose)
Table 11. World Radiopharmaceutical Average Price by Region (2027-2032) & (USD/Dose)
Table 12. Radiopharmaceutical Major Market Trends
Table 13. World Radiopharmaceutical Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Radiopharmaceutical Consumption by Region (2021-2026) & (K Dose)
Table 15. World Radiopharmaceutical Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Radiopharmaceutical Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Radiopharmaceutical Producers in 2025
Table 18. World Radiopharmaceutical Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Radiopharmaceutical Producers in 2025
Table 20. World Radiopharmaceutical Average Price by Manufacturer (2021-2026) & (USD/Dose)
Table 21. Global Radiopharmaceutical Company Evaluation Quadrant
Table 22. World Radiopharmaceutical Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Radiopharmaceutical Production Site of Key Manufacturer
Table 24. Radiopharmaceutical Market: Company Product Type Footprint
Table 25. Radiopharmaceutical Market: Company Product Application Footprint
Table 26. Radiopharmaceutical Competitive Factors
Table 27. Radiopharmaceutical New Entrant and Capacity Expansion Plans
Table 28. Radiopharmaceutical Mergers & Acquisitions Activity
Table 29. United States VS China Radiopharmaceutical Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Radiopharmaceutical Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Radiopharmaceutical Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Radiopharmaceutical Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Radiopharmaceutical Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Radiopharmaceutical Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Radiopharmaceutical Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Radiopharmaceutical Production Market Share (2021-2026)
Table 37. China Based Radiopharmaceutical Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Radiopharmaceutical Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Radiopharmaceutical Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Radiopharmaceutical Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Radiopharmaceutical Production Market Share (2021-2026)
Table 42. Rest of World Based Radiopharmaceutical Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Radiopharmaceutical Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Radiopharmaceutical Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Radiopharmaceutical Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Radiopharmaceutical Production Market Share (2021-2026)
Table 47. World Radiopharmaceutical Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Radiopharmaceutical Production by Type (2021-2026) & (K Dose)
Table 49. World Radiopharmaceutical Production by Type (2027-2032) & (K Dose)
Table 50. World Radiopharmaceutical Production Value by Type (2021-2026) & (USD Million)
Table 51. World Radiopharmaceutical Production Value by Type (2027-2032) & (USD Million)
Table 52. World Radiopharmaceutical Average Price by Type (2021-2026) & (USD/Dose)
Table 53. World Radiopharmaceutical Average Price by Type (2027-2032) & (USD/Dose)
Table 54. World Radiopharmaceutical Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Radiopharmaceutical Production by Application (2021-2026) & (K Dose)
Table 56. World Radiopharmaceutical Production by Application (2027-2032) & (K Dose)
Table 57. World Radiopharmaceutical Production Value by Application (2021-2026) & (USD Million)
Table 58. World Radiopharmaceutical Production Value by Application (2027-2032) & (USD Million)
Table 59. World Radiopharmaceutical Average Price by Application (2021-2026) & (USD/Dose)
Table 60. World Radiopharmaceutical Average Price by Application (2027-2032) & (USD/Dose)
Table 61. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 62. Cardinal Health Major Business
Table 63. Cardinal Health Radiopharmaceutical Product and Services
Table 64. Cardinal Health Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Cardinal Health Recent Developments/Updates
Table 66. Cardinal Health Competitive Strengths & Weaknesses
Table 67. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 68. GE Healthcare Major Business
Table 69. GE Healthcare Radiopharmaceutical Product and Services
Table 70. GE Healthcare Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. GE Healthcare Recent Developments/Updates
Table 72. GE Healthcare Competitive Strengths & Weaknesses
Table 73. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Jubilant Pharma Major Business
Table 75. Jubilant Pharma Radiopharmaceutical Product and Services
Table 76. Jubilant Pharma Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Jubilant Pharma Recent Developments/Updates
Table 78. Jubilant Pharma Competitive Strengths & Weaknesses
Table 79. Novartis Basic Information, Manufacturing Base and Competitors
Table 80. Novartis Major Business
Table 81. Novartis Radiopharmaceutical Product and Services
Table 82. Novartis Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Novartis Recent Developments/Updates
Table 84. Novartis Competitive Strengths & Weaknesses
Table 85. Curium Pharma Basic Information, Manufacturing Base and Competitors
Table 86. Curium Pharma Major Business
Table 87. Curium Pharma Radiopharmaceutical Product and Services
Table 88. Curium Pharma Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Curium Pharma Recent Developments/Updates
Table 90. Curium Pharma Competitive Strengths & Weaknesses
Table 91. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 92. SIEMENS Major Business
Table 93. SIEMENS Radiopharmaceutical Product and Services
Table 94. SIEMENS Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. SIEMENS Recent Developments/Updates
Table 96. SIEMENS Competitive Strengths & Weaknesses
Table 97. Lantheus Basic Information, Manufacturing Base and Competitors
Table 98. Lantheus Major Business
Table 99. Lantheus Radiopharmaceutical Product and Services
Table 100. Lantheus Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. Lantheus Recent Developments/Updates
Table 102. Lantheus Competitive Strengths & Weaknesses
Table 103. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 104. Bracco Imaging Major Business
Table 105. Bracco Imaging Radiopharmaceutical Product and Services
Table 106. Bracco Imaging Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. Bracco Imaging Recent Developments/Updates
Table 108. Bracco Imaging Competitive Strengths & Weaknesses
Table 109. Bayer Basic Information, Manufacturing Base and Competitors
Table 110. Bayer Major Business
Table 111. Bayer Radiopharmaceutical Product and Services
Table 112. Bayer Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. Bayer Recent Developments/Updates
Table 114. Bayer Competitive Strengths & Weaknesses
Table 115. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 116. Eli Lilly Major Business
Table 117. Eli Lilly Radiopharmaceutical Product and Services
Table 118. Eli Lilly Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Eli Lilly Recent Developments/Updates
Table 120. Eli Lilly Competitive Strengths & Weaknesses
Table 121. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 122. Aurobindo Pharma Major Business
Table 123. Aurobindo Pharma Radiopharmaceutical Product and Services
Table 124. Aurobindo Pharma Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Aurobindo Pharma Recent Developments/Updates
Table 126. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 127. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 128. Mundipharma Major Business
Table 129. Mundipharma Radiopharmaceutical Product and Services
Table 130. Mundipharma Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 131. Mundipharma Recent Developments/Updates
Table 132. Mundipharma Competitive Strengths & Weaknesses
Table 133. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 134. China Isotope & Radiation Major Business
Table 135. China Isotope & Radiation Radiopharmaceutical Product and Services
Table 136. China Isotope & Radiation Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 137. China Isotope & Radiation Recent Developments/Updates
Table 138. China Isotope & Radiation Competitive Strengths & Weaknesses
Table 139. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 140. Dongcheng Major Business
Table 141. Dongcheng Radiopharmaceutical Product and Services
Table 142. Dongcheng Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 143. Dongcheng Recent Developments/Updates
Table 144. Dongcheng Competitive Strengths & Weaknesses
Table 145. Global Key Players of Radiopharmaceutical Upstream (Raw Materials)
Table 146. Global Radiopharmaceutical Typical Customers
Table 147. Radiopharmaceutical Typical Distributors
Table 1. World Radiopharmaceutical Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Radiopharmaceutical Production Value by Region (2021-2026) & (USD Million)
Table 3. World Radiopharmaceutical Production Value by Region (2027-2032) & (USD Million)
Table 4. World Radiopharmaceutical Production Value Market Share by Region (2021-2026)
Table 5. World Radiopharmaceutical Production Value Market Share by Region (2027-2032)
Table 6. World Radiopharmaceutical Production by Region (2021-2026) & (K Dose)
Table 7. World Radiopharmaceutical Production by Region (2027-2032) & (K Dose)
Table 8. World Radiopharmaceutical Production Market Share by Region (2021-2026)
Table 9. World Radiopharmaceutical Production Market Share by Region (2027-2032)
Table 10. World Radiopharmaceutical Average Price by Region (2021-2026) & (USD/Dose)
Table 11. World Radiopharmaceutical Average Price by Region (2027-2032) & (USD/Dose)
Table 12. Radiopharmaceutical Major Market Trends
Table 13. World Radiopharmaceutical Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Radiopharmaceutical Consumption by Region (2021-2026) & (K Dose)
Table 15. World Radiopharmaceutical Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Radiopharmaceutical Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Radiopharmaceutical Producers in 2025
Table 18. World Radiopharmaceutical Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Radiopharmaceutical Producers in 2025
Table 20. World Radiopharmaceutical Average Price by Manufacturer (2021-2026) & (USD/Dose)
Table 21. Global Radiopharmaceutical Company Evaluation Quadrant
Table 22. World Radiopharmaceutical Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Radiopharmaceutical Production Site of Key Manufacturer
Table 24. Radiopharmaceutical Market: Company Product Type Footprint
Table 25. Radiopharmaceutical Market: Company Product Application Footprint
Table 26. Radiopharmaceutical Competitive Factors
Table 27. Radiopharmaceutical New Entrant and Capacity Expansion Plans
Table 28. Radiopharmaceutical Mergers & Acquisitions Activity
Table 29. United States VS China Radiopharmaceutical Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Radiopharmaceutical Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Radiopharmaceutical Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Radiopharmaceutical Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Radiopharmaceutical Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Radiopharmaceutical Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Radiopharmaceutical Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Radiopharmaceutical Production Market Share (2021-2026)
Table 37. China Based Radiopharmaceutical Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Radiopharmaceutical Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Radiopharmaceutical Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Radiopharmaceutical Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Radiopharmaceutical Production Market Share (2021-2026)
Table 42. Rest of World Based Radiopharmaceutical Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Radiopharmaceutical Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Radiopharmaceutical Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Radiopharmaceutical Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Radiopharmaceutical Production Market Share (2021-2026)
Table 47. World Radiopharmaceutical Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Radiopharmaceutical Production by Type (2021-2026) & (K Dose)
Table 49. World Radiopharmaceutical Production by Type (2027-2032) & (K Dose)
Table 50. World Radiopharmaceutical Production Value by Type (2021-2026) & (USD Million)
Table 51. World Radiopharmaceutical Production Value by Type (2027-2032) & (USD Million)
Table 52. World Radiopharmaceutical Average Price by Type (2021-2026) & (USD/Dose)
Table 53. World Radiopharmaceutical Average Price by Type (2027-2032) & (USD/Dose)
Table 54. World Radiopharmaceutical Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Radiopharmaceutical Production by Application (2021-2026) & (K Dose)
Table 56. World Radiopharmaceutical Production by Application (2027-2032) & (K Dose)
Table 57. World Radiopharmaceutical Production Value by Application (2021-2026) & (USD Million)
Table 58. World Radiopharmaceutical Production Value by Application (2027-2032) & (USD Million)
Table 59. World Radiopharmaceutical Average Price by Application (2021-2026) & (USD/Dose)
Table 60. World Radiopharmaceutical Average Price by Application (2027-2032) & (USD/Dose)
Table 61. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 62. Cardinal Health Major Business
Table 63. Cardinal Health Radiopharmaceutical Product and Services
Table 64. Cardinal Health Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Cardinal Health Recent Developments/Updates
Table 66. Cardinal Health Competitive Strengths & Weaknesses
Table 67. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 68. GE Healthcare Major Business
Table 69. GE Healthcare Radiopharmaceutical Product and Services
Table 70. GE Healthcare Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. GE Healthcare Recent Developments/Updates
Table 72. GE Healthcare Competitive Strengths & Weaknesses
Table 73. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Jubilant Pharma Major Business
Table 75. Jubilant Pharma Radiopharmaceutical Product and Services
Table 76. Jubilant Pharma Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Jubilant Pharma Recent Developments/Updates
Table 78. Jubilant Pharma Competitive Strengths & Weaknesses
Table 79. Novartis Basic Information, Manufacturing Base and Competitors
Table 80. Novartis Major Business
Table 81. Novartis Radiopharmaceutical Product and Services
Table 82. Novartis Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Novartis Recent Developments/Updates
Table 84. Novartis Competitive Strengths & Weaknesses
Table 85. Curium Pharma Basic Information, Manufacturing Base and Competitors
Table 86. Curium Pharma Major Business
Table 87. Curium Pharma Radiopharmaceutical Product and Services
Table 88. Curium Pharma Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Curium Pharma Recent Developments/Updates
Table 90. Curium Pharma Competitive Strengths & Weaknesses
Table 91. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 92. SIEMENS Major Business
Table 93. SIEMENS Radiopharmaceutical Product and Services
Table 94. SIEMENS Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. SIEMENS Recent Developments/Updates
Table 96. SIEMENS Competitive Strengths & Weaknesses
Table 97. Lantheus Basic Information, Manufacturing Base and Competitors
Table 98. Lantheus Major Business
Table 99. Lantheus Radiopharmaceutical Product and Services
Table 100. Lantheus Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. Lantheus Recent Developments/Updates
Table 102. Lantheus Competitive Strengths & Weaknesses
Table 103. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 104. Bracco Imaging Major Business
Table 105. Bracco Imaging Radiopharmaceutical Product and Services
Table 106. Bracco Imaging Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. Bracco Imaging Recent Developments/Updates
Table 108. Bracco Imaging Competitive Strengths & Weaknesses
Table 109. Bayer Basic Information, Manufacturing Base and Competitors
Table 110. Bayer Major Business
Table 111. Bayer Radiopharmaceutical Product and Services
Table 112. Bayer Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. Bayer Recent Developments/Updates
Table 114. Bayer Competitive Strengths & Weaknesses
Table 115. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 116. Eli Lilly Major Business
Table 117. Eli Lilly Radiopharmaceutical Product and Services
Table 118. Eli Lilly Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Eli Lilly Recent Developments/Updates
Table 120. Eli Lilly Competitive Strengths & Weaknesses
Table 121. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 122. Aurobindo Pharma Major Business
Table 123. Aurobindo Pharma Radiopharmaceutical Product and Services
Table 124. Aurobindo Pharma Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Aurobindo Pharma Recent Developments/Updates
Table 126. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 127. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 128. Mundipharma Major Business
Table 129. Mundipharma Radiopharmaceutical Product and Services
Table 130. Mundipharma Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 131. Mundipharma Recent Developments/Updates
Table 132. Mundipharma Competitive Strengths & Weaknesses
Table 133. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 134. China Isotope & Radiation Major Business
Table 135. China Isotope & Radiation Radiopharmaceutical Product and Services
Table 136. China Isotope & Radiation Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 137. China Isotope & Radiation Recent Developments/Updates
Table 138. China Isotope & Radiation Competitive Strengths & Weaknesses
Table 139. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 140. Dongcheng Major Business
Table 141. Dongcheng Radiopharmaceutical Product and Services
Table 142. Dongcheng Radiopharmaceutical Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 143. Dongcheng Recent Developments/Updates
Table 144. Dongcheng Competitive Strengths & Weaknesses
Table 145. Global Key Players of Radiopharmaceutical Upstream (Raw Materials)
Table 146. Global Radiopharmaceutical Typical Customers
Table 147. Radiopharmaceutical Typical Distributors
LIST OF FIGURES
Figure 1. Radiopharmaceutical Picture
Figure 2. World Radiopharmaceutical Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Radiopharmaceutical Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Radiopharmaceutical Production (2021-2032) & (K Dose)
Figure 5. World Radiopharmaceutical Average Price (2021-2032) & (USD/Dose)
Figure 6. World Radiopharmaceutical Production Value Market Share by Region (2021-2032)
Figure 7. World Radiopharmaceutical Production Market Share by Region (2021-2032)
Figure 8. North America Radiopharmaceutical Production (2021-2032) & (K Dose)
Figure 9. Europe Radiopharmaceutical Production (2021-2032) & (K Dose)
Figure 10. China Radiopharmaceutical Production (2021-2032) & (K Dose)
Figure 11. Japan Radiopharmaceutical Production (2021-2032) & (K Dose)
Figure 12. India Radiopharmaceutical Production (2021-2032) & (K Dose)
Figure 13. Radiopharmaceutical Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Radiopharmaceutical Consumption (2021-2032) & (K Dose)
Figure 16. World Radiopharmaceutical Consumption Market Share by Region (2021-2032)
Figure 17. United States Radiopharmaceutical Consumption (2021-2032) & (K Dose)
Figure 18. China Radiopharmaceutical Consumption (2021-2032) & (K Dose)
Figure 19. Europe Radiopharmaceutical Consumption (2021-2032) & (K Dose)
Figure 20. Japan Radiopharmaceutical Consumption (2021-2032) & (K Dose)
Figure 21. South Korea Radiopharmaceutical Consumption (2021-2032) & (K Dose)
Figure 22. ASEAN Radiopharmaceutical Consumption (2021-2032) & (K Dose)
Figure 23. India Radiopharmaceutical Consumption (2021-2032) & (K Dose)
Figure 24. Producer Shipments of Radiopharmaceutical by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Radiopharmaceutical Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Radiopharmaceutical Markets in 2025
Figure 27. United States VS China: Radiopharmaceutical Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Radiopharmaceutical Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Radiopharmaceutical Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Radiopharmaceutical Production Market Share 2025
Figure 31. China Based Manufacturers Radiopharmaceutical Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Radiopharmaceutical Production Market Share 2025
Figure 33. World Radiopharmaceutical Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Radiopharmaceutical Production Value Market Share by Type in 2025
Figure 35. Diagnostic Radiopharmaceuticals
Figure 36. Therapeutic Radiopharmaceuticals
Figure 37. World Radiopharmaceutical Production Market Share by Type (2021-2032)
Figure 38. World Radiopharmaceutical Production Value Market Share by Type (2021-2032)
Figure 39. World Radiopharmaceutical Average Price by Type (2021-2032) & (USD/Dose)
Figure 40. World Radiopharmaceutical Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 41. World Radiopharmaceutical Production Value Market Share by Application in 2025
Figure 42. Oncology
Figure 43. Cardiology
Figure 44. Other
Figure 45. World Radiopharmaceutical Production Market Share by Application (2021-2032)
Figure 46. World Radiopharmaceutical Production Value Market Share by Application (2021-2032)
Figure 47. World Radiopharmaceutical Average Price by Application (2021-2032) & (USD/Dose)
Figure 48. Radiopharmaceutical Industry Chain
Figure 49. Radiopharmaceutical Procurement Model
Figure 50. Radiopharmaceutical Sales Model
Figure 51. Radiopharmaceutical Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Radiopharmaceutical Picture
Figure 2. World Radiopharmaceutical Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Radiopharmaceutical Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Radiopharmaceutical Production (2021-2032) & (K Dose)
Figure 5. World Radiopharmaceutical Average Price (2021-2032) & (USD/Dose)
Figure 6. World Radiopharmaceutical Production Value Market Share by Region (2021-2032)
Figure 7. World Radiopharmaceutical Production Market Share by Region (2021-2032)
Figure 8. North America Radiopharmaceutical Production (2021-2032) & (K Dose)
Figure 9. Europe Radiopharmaceutical Production (2021-2032) & (K Dose)
Figure 10. China Radiopharmaceutical Production (2021-2032) & (K Dose)
Figure 11. Japan Radiopharmaceutical Production (2021-2032) & (K Dose)
Figure 12. India Radiopharmaceutical Production (2021-2032) & (K Dose)
Figure 13. Radiopharmaceutical Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Radiopharmaceutical Consumption (2021-2032) & (K Dose)
Figure 16. World Radiopharmaceutical Consumption Market Share by Region (2021-2032)
Figure 17. United States Radiopharmaceutical Consumption (2021-2032) & (K Dose)
Figure 18. China Radiopharmaceutical Consumption (2021-2032) & (K Dose)
Figure 19. Europe Radiopharmaceutical Consumption (2021-2032) & (K Dose)
Figure 20. Japan Radiopharmaceutical Consumption (2021-2032) & (K Dose)
Figure 21. South Korea Radiopharmaceutical Consumption (2021-2032) & (K Dose)
Figure 22. ASEAN Radiopharmaceutical Consumption (2021-2032) & (K Dose)
Figure 23. India Radiopharmaceutical Consumption (2021-2032) & (K Dose)
Figure 24. Producer Shipments of Radiopharmaceutical by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Radiopharmaceutical Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Radiopharmaceutical Markets in 2025
Figure 27. United States VS China: Radiopharmaceutical Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Radiopharmaceutical Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Radiopharmaceutical Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Radiopharmaceutical Production Market Share 2025
Figure 31. China Based Manufacturers Radiopharmaceutical Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Radiopharmaceutical Production Market Share 2025
Figure 33. World Radiopharmaceutical Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Radiopharmaceutical Production Value Market Share by Type in 2025
Figure 35. Diagnostic Radiopharmaceuticals
Figure 36. Therapeutic Radiopharmaceuticals
Figure 37. World Radiopharmaceutical Production Market Share by Type (2021-2032)
Figure 38. World Radiopharmaceutical Production Value Market Share by Type (2021-2032)
Figure 39. World Radiopharmaceutical Average Price by Type (2021-2032) & (USD/Dose)
Figure 40. World Radiopharmaceutical Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 41. World Radiopharmaceutical Production Value Market Share by Application in 2025
Figure 42. Oncology
Figure 43. Cardiology
Figure 44. Other
Figure 45. World Radiopharmaceutical Production Market Share by Application (2021-2032)
Figure 46. World Radiopharmaceutical Production Value Market Share by Application (2021-2032)
Figure 47. World Radiopharmaceutical Average Price by Application (2021-2032) & (USD/Dose)
Figure 48. Radiopharmaceutical Industry Chain
Figure 49. Radiopharmaceutical Procurement Model
Figure 50. Radiopharmaceutical Sales Model
Figure 51. Radiopharmaceutical Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
